Status | Study |
Suspended |
Study Name: Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma Condition: AIDS-Related Hodgkin Lymphoma AIDS-Related Non-Hodgkin Lymphoma Date: 2015-02-27 Interventions: Biological: Gene-Modified HIV-Protected Hematopoietic Stem Cells |
Recruiting |
Study Name: Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma Condition: AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma Date: 2013-01-23 Interventions: Drug: cyclophosphamide Given I |
Withdrawn |
Study Name: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma AIDS-related Diffuse Large Cell Lymphoma Date: 2013-01-15 Interventions: Drug: carmustine Given IV |
Completed |
Study Name: High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk Condition: HIV-related Lymphoma HIV Infections Date: 2010-01-08 Interventions: Other: Rituximab and CHOP regimen + PBSCT Other Names: Mabthera |
Active, not recruiting |
Study Name: Cohort of HIV Associated Lymphomas Condition: HIV Infection Date: 2009-12-22 |
Suspended |
Study Name: High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT Condition: AIDS-related Lymphoma HIV Infections Date: 2009-03-09 Interventions: Procedure: PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC) Patient stem |
Completed |
Study Name: A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL Condition: Lymphoma, AIDS Related HIV Infections Date: 2008-11-26 Interventions: Drug: R-EPOCH and cART This is a prospective, single-arm, multi-centre, phase II trial of immuno-chemoth |
Active, not recruiting |
Study Name: Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma Condition: Lymphoma Date: 2008-03-21 Interventions: Drug: carmustine 150 mg/m2 day |
Active, not recruiting |
Study Name: Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma Condition: Lymphoma Date: 2007-12-07 Interventions: Biological: lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic |
Withdrawn |
Study Name: Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Condition: AIDS-related Lymphoma Adult Non-Hodgkin's Lymphoma Date: 2006-03-29 Interventions: Drug: cisplatin Drug: cytarabine |